Clinical trials
Phase 2 Muscular Atrophy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Baltimore VA Medical Center | 1 |
| Baylor College of Medicine | 1 |
| Eli Lilly and Company | 1 |
| Faraday Pharmaceuticals, Inc. | 1 |
| GTx | 1 |
| Hospital for Special Surgery, New York | 1 |
| Michael C Willey | 1 |
| Scholar Rock, Inc. | 1 |
| Tufts University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy | 21 |
| Sarcopenia | 4 |
| Atrophy | 2 |
| Cachexia | 2 |
| Insulin Resistance | 2 |
| Muscle Weakness | 2 |
| Obesity | 2 |
| Anterior Cruciate Ligament Injuries | 1 |
| Asthenia | 1 |
| COVID-19 | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.